Full Text View
Tabular View
No Study Results Posted
Related Studies
Identifying the Role of Oxytocin and Vasopressin in the Functioning of Neurocognitive Systems Involved in Mood Disorders
This study is currently recruiting participants.
Study NCT00325065   Information provided by National Institutes of Health Clinical Center (CC)
First Received: May 11, 2006   Last Updated: August 24, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Mood Disorders
Additional conditions recognized in this trial
Disease
More general conditions related to this trial
Mental Disorders
Pathologic Processes
Additional drug interventions recognized in this trial
Arginine Vasopressin
Oxytocin
Vasopressins
More general drug interventions related to this trial
Antidiuretic Agents
Cardiovascular Agents
Coagulants
Hematologic Agents
Hemostatics
Natriuretic Agents
Oxytocics
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
National Institute of Mental Health (NIMH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services